264#Background:Black men in the United States are considered a high-risk population for being diagnosed with and dying from prostate cancer. Few guidelines have outlined specific recommendations for prostate-specific antigen (PSA)-based prostate cancer screening among Black men. We performed a ...
Prostate specific antigen (PSA) is an exceptional biomarker for prostate cancer. While there has been a significant decrease in prostate cancer mortality since the introduction of PSA screening, the benefit of screening can be diminished by the loss of quality of life (QoL) stemming from both the...
The guidelines recommend that Black men should obtain information about PSA screening for prostate cancer. Among Black men who elect screening, baseline PSA testing should occur between ages 40 and 45. Depending on PSA value and health status, annual screening should be strongly considered, the ...
Genetic testing, to identify pathogenic or likely pathogenic variants in prostate cancer, is valuable in guiding treatment decisions for men with prostate cancer and to inform cancer prevention and early detection options for their immediate blood relati
(PSA) remains as the most used biomarker in the detection of early PCa. However, since 2009, PSA usefulness in PCa screening has been widely argued following the opposite results obtained in the two largest randomized screening studies. The European Randomized Study of Screening for Prostate ...
The European Randomized Study of Screening for Prostate Cancer (ERSPC) found a survival benefit to screening, while the United States Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial did not. Furthermore, the benefit of immediate surgical intervention for screen-detected prostate...
The exposure rate of screening for prostate cancer using prostate-specific antigen (PSA) in Japan is still very low compared with that in the USA or Western Europe. The mortality rate of prostate cancer will increase in the future and in 2020 it will be 2.8 times higher than in 2000. Ther...
(Prostate MRI and Molecular Imaging ) 1:03:02 RSNA 2022:肺血管影像学—肺动脉高压CT (Pulmonary Vascular Imaging CTEPHPulmonary Hypertension 1:01:52 RSNA 2022:平滑肌肉瘤vs平滑肌瘤:多参数磁共振成像(The Leiomyosarcoma vs Leiomyoma ) 55:49 RSNA 2022: 人工智能在神经影像学的临床应即将到来AI ...
Active Surveillance for Prostate Cancer: Progress and Promise Widespread prostate-specific antigen (PSA) -based screening and aggressive treatment of prostate cancer have reduced mortality rates substantially, but bot... MR Cooperberg,PR Carroll,L Klotz - 《Journal of Clinical Oncology Official Journal...
statement titled “Intimate Partner Violence and Caregiver Abuse of Older or Vulnerable Adults: Screening,” which was published online on October 29, 2024. In accordance with the latest screening guidelines, the USPSTF recommends that clinicians screen for intimate partner violence (IPV) in pregnant ...